These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31963931)

  • 21. Exosomes as nucleic acid nanocarriers.
    van den Boorn JG; Dassler J; Coch C; Schlee M; Hartmann G
    Adv Drug Deliv Rev; 2013 Mar; 65(3):331-5. PubMed ID: 22750807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
    Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation, contents, functions of exosomes and their potential in lung cancer diagnostics and therapeutics.
    Xia Z; Qing B; Wang W; Gu L; Chen H; Yuan Y
    Thorac Cancer; 2021 Dec; 12(23):3088-3100. PubMed ID: 34734680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The exosome: a review of current therapeutic roles and capabilities in human reproduction.
    Dimik M; Abeysinghe P; Logan J; Mitchell M
    Drug Deliv Transl Res; 2023 Feb; 13(2):473-502. PubMed ID: 35980542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of Emerging Plant-Derived Nanoparticles as a Novel Approach for Nano-Drug Delivery Systems.
    Sarvarian P; Samadi P; Gholipour E; Shams Asenjan K; Hojjat-Farsangi M; Motavalli R; Motavalli Khiavi F; Yousefi M
    Immunol Invest; 2022 May; 51(4):1039-1059. PubMed ID: 33627016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered Exosomes as Vehicles for Biologically Active Proteins.
    Sterzenbach U; Putz U; Low LH; Silke J; Tan SS; Howitt J
    Mol Ther; 2017 Jun; 25(6):1269-1278. PubMed ID: 28412169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosome as a Delivery Vehicle for Cancer Therapy.
    Moon B; Chang S
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
    Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives.
    Liu Q; Li S; Dupuy A; Mai HL; Sailliet N; Logé C; Robert JH; Brouard S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
    Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
    Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review on the use of extracellular vesicles for the delivery of drugs and biological therapeutics.
    Amina SJ; Azam T; Dagher F; Guo B
    Expert Opin Drug Deliv; 2024; 21(1):45-70. PubMed ID: 38226932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functionalized DNA Enables Programming Exosomes/Vesicles for Tumor Imaging and Therapy.
    Fan Z; Xiao K; Lin J; Liao Y; Huang X
    Small; 2019 Nov; 15(47):e1903761. PubMed ID: 31614072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New advances in exosome-based targeted drug delivery systems.
    Ferreira D; Moreira JN; Rodrigues LR
    Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges.
    Shahabipour F; Banach M; Sahebkar A
    Arch Med Sci; 2016 Dec; 12(6):1324-1326. PubMed ID: 27904525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction.
    Sun W; Li Z; Zhou X; Yang G; Yuan L
    Drug Deliv; 2019 Dec; 26(1):45-50. PubMed ID: 30744440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Delivery to the Bone Microenvironment Mediated by Exosomes: An Axiom or Enigma.
    Samal S; Dash P; Dash M
    Int J Nanomedicine; 2021; 16():3509-3540. PubMed ID: 34045855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focus on exosomes-From pathogenic mechanisms to the potential clinical application value in lymphoma.
    Liu J; Wang X
    J Cell Biochem; 2019 Dec; 120(12):19220-19228. PubMed ID: 31452241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.